Sign Up to like & get
recommendations!
2
Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51553
Abstract: Plasma phosphorylated‐tau‐181 (p‐tau181) reliably detects clinical Alzheimer's disease (AD) as well as asymptomatic amyloid‐β (Aβ) pathology, but is consistently quantified with assays using antibody AT270, which cross‐reacts with p‐tau175. This study investigates two novel phospho‐specific…
read more here.
Keywords:
well asymptomatic;
alzheimer disease;
detects clinical;
plasma tau181 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "ACS chemical neuroscience"
DOI: 10.1021/acschemneuro.2c00636
Abstract: Blood-based biomarkers have been considered as a promising method for the diagnosis of Alzheimer's disease (AD). The reliability and accuracy of plasma core AD biomarkers, including phosphorylated tau (P-tau181), total tau (T-tau), Aβ42, and Aβ40,…
read more here.
Keywords:
plasma core;
plasma;
tau;
plasma tau181 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Nature Medicine"
DOI: 10.1038/s41591-020-0755-1
Abstract: Plasma phosphorylated tau181 (P-tau181) might be increased in Alzheimer’s disease (AD), but its usefulness for differential diagnosis and prognosis is unclear. We studied plasma P-tau181 in three cohorts, with a total of 589 individuals, including…
read more here.
Keywords:
dementia;
alzheimer disease;
tau181;
plasma tau181 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of Alzheimer's Disease"
DOI: 10.3233/jad-210673
Abstract: Background: The Apolipoprotein E (APOE) ɛ4 allele has been linked to increased tau phosphorylation and tangle formation. APOE ɛ4 carriers with elevated tau might be at the higher risk for Alzheimer’s disease (AD) progression. Previous…
read more here.
Keywords:
tau181 preclinical;
disease;
association apoe;
hippocampus ... See more keywords